Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively represent a full-spectrum med-spa offering a blend of anti-aging, aesthetic, wellness, and sexual health services in South Florida. This physician-led medical spa and wellness clinic was established in 2018 and has earned a strong reputation as a trusted destination for clients seeking both vitality and aesthetics, offering an uncommon combination of advanced medicine, sexual wellness, and non-invasive cosmetic treatments.

With a focus on cutting-edge technology and medically backed treatments, this medical spa offers its clients both cosmetic enhancement and wellness services to address their beauty and self-care needs. Each client receives a customized consultation to develop a treatment plan that aligns with their beauty goals, skin type, and body concerns.

In a competitive analysis, the Company stands out with its medically sophisticated, integrated approach across aesthetics, wellness, and longevity—an appealing model for higher-income or medically-minded clients in the market.

The company accepts private-pay clients only, does not bill insurance, and therefore collects all payments from the patient.

Facility

The company leases a beautiful 3,000 square foot space in a modern medical building on a main thoroughfare in an affluent market. It includes multiple private treatment rooms, a salt room, a relaxation room, and a lounge within the office. It is an inviting, comfortable space designed for new patients to learn about services and feel at ease while consulting with the staff.

The company has over $1 million of state-of-the-art equipment including:

Softwave, OxyGeneo, Try-lift, Piq04, XEO, and Stellar M22, and EBOO machine, an Emcyte centrifuge, and several shockwave devices.

Financial Overview

The company has experienced significant revenue and earnings growth over the past few years, reflecting its strong market position and loyal customer base. Gross Revenue has increased over the past few years, reaching $3,003,515 in 2024. Adjusted EBITDA has also been on an upward trajectory, surpassing $500,000 in 2024. In 2025, they grossed $1,825,380 through July, putting them on pace to reach $3,129,222 by the end of the year. Adjusted EBITDA through July 2025 was $293,518, and they expect to reach $503,174 by year end. 

Industry Note

In 2025, there has been a nationwide MedSpa market slowdown, with major players like Allergan and Galderma reporting similar trends of up to 30%, driven by broader economic and geopolitical factors, not company-specific issues.

Despite the dip, the Company has continued to demonstrate resilience, maintaining revenue growth and profitability through its affluent market, high-value service mix, and integrated medical approach.

This makes it an ideal acquisition platform for investors or physician-operators seeking to expand in one of the country’s most attractive markets.

Staff Overview

The company employs a dedicated team of 8 professionals, including the 2 provider-partners, a Nurse Practitioner and a Physician, all of whom are expected to stay on under new ownership. Staff consists of a Laser Tech; A Receptionist and Organizer; a Medical Assistant; 2 Sales and Wellness Consultants;  and a Purchasing Manager for Meds and Compounds. The provider partners will assist during a transitional period to ensure the continued success of the business and will be available to remain indefinitely as will the balance of the staff.

Asking Price

The asking price for this opportunity is $2.9 million, which does not include cash, receivables, or working capital..